$INFU
InfuSystem Holdings, Inc

2013 Q4 Form 10-Q Financial Statement

#000119312513437022 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $17.18M $15.74M $14.18M
YoY Change 5.85% 11.04% -2.31%
Cost Of Revenue $4.400M $2.750M $2.377M
YoY Change 4.02% 15.69% -54.9%
Gross Profit $12.78M $11.34M $10.20M
YoY Change 6.5% 11.21% 10.48%
Gross Profit Margin 74.39% 72.05% 71.94%
Selling, General & Admin $8.380M $6.974M $7.627M
YoY Change -13.96% -8.56% -0.43%
% of Gross Profit 65.57% 61.5% 74.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.040M $100.0K $100.0K
YoY Change -4.29% 0.0% -95.83%
% of Gross Profit 62.91% 0.88% 0.98%
Operating Expenses $9.130M $9.417M $9.276M
YoY Change -12.55% 1.52% 11.09%
Operating Profit $3.650M $1.923M $921.0K
YoY Change 133.97% 108.79% 4.66%
Interest Expense -$860.0K $838.0K $971.0K
YoY Change -22.52% -13.7% -279.81%
% of Operating Profit -23.56% 43.58% 105.43%
Other Income/Expense, Net -$30.00K -$845.0K -$1.107M
YoY Change 200.0% -23.67% 822.5%
Pretax Income $1.570M $1.078M -$186.0K
YoY Change 375.76% -679.57% -99.2%
Income Tax $710.0K $429.0K -$219.0K
% Of Pretax Income 45.22% 39.8%
Net Earnings $860.0K $649.0K $33.00K
YoY Change 290.91% 1866.67% -100.2%
Net Earnings / Revenue 5.01% 4.12% 0.23%
Basic Earnings Per Share $0.03 $0.00
Diluted Earnings Per Share $38.79K $0.03 $0.00
COMMON SHARES
Basic Shares Outstanding 22.09M shares 21.89M shares 21.60M shares
Diluted Shares Outstanding 22.08M shares 21.83M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.100M $900.0K $1.500M
YoY Change -52.17% -40.0% 275.0%
Cash & Equivalents $1.138M $908.0K $1.464M
Short-Term Investments
Other Short-Term Assets $518.0K $625.0K $1.300M
YoY Change -24.27% -51.92% -35.0%
Inventory $1.234M $1.343M $3.800M
Prepaid Expenses
Receivables $10.70M $9.291M $7.600M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.88M $14.15M $14.20M
YoY Change 7.09% -0.33% 12.7%
LONG-TERM ASSETS
Property, Plant & Equipment $872.0K $813.0K $14.00M
YoY Change 0.58% -94.19% -17.16%
Goodwill
YoY Change
Intangibles $24.18M $24.08M
YoY Change -5.32%
Long-Term Investments
YoY Change
Other Assets $217.0K $184.0K $19.50M
YoY Change -48.21% -99.06% -8.88%
Total Long-Term Assets $61.49M $62.24M $59.80M
YoY Change -1.92% 4.08% -10.61%
TOTAL ASSETS
Total Short-Term Assets $15.88M $14.15M $14.20M
Total Long-Term Assets $61.49M $62.24M $59.80M
Total Assets $77.37M $76.39M $74.00M
YoY Change -0.19% 3.23% -6.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.736M $4.329M $4.900M
YoY Change 121.83% -11.65% 157.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $1.500M
YoY Change -100.0%
Long-Term Debt Due $5.118M $3.239M $22.40M
YoY Change 29.47% -85.54% 234.33%
Total Short-Term Liabilities $13.04M $10.39M $32.80M
YoY Change 27.92% -68.32% 198.18%
LONG-TERM LIABILITIES
Long-Term Debt $21.61M $24.38M $1.900M
YoY Change -20.89% 1183.16% -92.12%
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $21.61M $24.38M $1.900M
YoY Change -20.89% 1183.16% -92.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.04M $10.39M $32.80M
Total Long-Term Liabilities $21.61M $24.38M $1.900M
Total Liabilities $34.65M $34.77M $34.70M
YoY Change -7.62% 0.21% -10.57%
SHAREHOLDERS EQUITY
Retained Earnings -$47.06M -$47.93M
YoY Change -3.42%
Common Stock $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.72M $41.62M $39.30M
YoY Change
Total Liabilities & Shareholders Equity $77.37M $76.39M $74.00M
YoY Change -0.19% 3.23% -6.92%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $860.0K $649.0K $33.00K
YoY Change 290.91% 1866.67% -100.2%
Depreciation, Depletion And Amortization $8.040M $100.0K $100.0K
YoY Change -4.29% 0.0% -95.83%
Cash From Operating Activities $2.690M $2.540M $2.170M
YoY Change -807.89% 17.05% 181.82%
INVESTING ACTIVITIES
Capital Expenditures -$2.560M -$840.0K -$2.580M
YoY Change 14.8% -67.44% 183.52%
Acquisitions
YoY Change
Other Investing Activities $990.0K $1.080M $3.600M
YoY Change 115.22% -70.0%
Cash From Investing Activities -$1.570M $250.0K $1.020M
YoY Change -11.3% -75.49% -212.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -890.0K -1.980M -2.530M
YoY Change -129.57% -21.74% 120.0%
NET CHANGE
Cash From Operating Activities 2.690M 2.540M 2.170M
Cash From Investing Activities -1.570M 250.0K 1.020M
Cash From Financing Activities -890.0K -1.980M -2.530M
Net Change In Cash 230.0K 810.0K 660.0K
YoY Change -73.26% 22.73% -151.16%
FREE CASH FLOW
Cash From Operating Activities $2.690M $2.540M $2.170M
Capital Expenditures -$2.560M -$840.0K -$2.580M
Free Cash Flow $5.250M $3.380M $4.750M
YoY Change 183.78% -28.84% 182.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
64100000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1464000
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22085031 shares
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2191000
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1986000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
646000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2191000
CY2013Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
17259000
CY2013Q3 us-gaap Assets
Assets
76392000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
908000
CY2013Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0950 pure
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22088731 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3228000
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24380000
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89544000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4329000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10392000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
41620000
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4178000
CY2013Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
0
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47926000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76392000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3252000
CY2013Q3 us-gaap Long Term Debt
LongTermDebt
27619000
CY2013Q3 us-gaap Liabilities
Liabilities
34772000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
803000
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2824000
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
20336000
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3239000
CY2013Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
37867000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
11537000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
14153000
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24075000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
184000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9291000
CY2013Q3 us-gaap Inventory Net
InventoryNet
1343000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2468000
CY2013Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
100000
CY2013Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1972000
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
625000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2279000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
813000
CY2013Q3 infu Line Of Credit Facility Current Borrowing Capacity In Year One
LineOfCreditFacilityCurrentBorrowingCapacityInYearOne
5500000
CY2012Q4 us-gaap Liabilities
Liabilities
37510000
CY2013Q3 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
103000
CY2013Q3 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
13792000
CY2013Q3 infu Medical Equipment Net
MedicalEquipmentNet
17936000
CY2013Q3 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
21996000
CY2013Q3 infu Line Of Credit Facility Current Borrowing Capacity In Year Two
LineOfCreditFacilityCurrentBorrowingCapacityInYearTwo
5500000
CY2013Q3 infu Line Of Credit Facility Current Borrowing Capacity In Year Three
LineOfCreditFacilityCurrentBorrowingCapacityInYearThree
5500000
CY2013Q3 infu Line Of Credit Facility Current Borrowing Capacity In Year Four
LineOfCreditFacilityCurrentBorrowingCapacityInYearFour
5500000
CY2013Q3 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2995000
CY2013Q3 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
14941000
CY2013Q3 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
37040000
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22085031 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
799000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21802515 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21990000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
27315000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
88742000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2135000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10195000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
40013000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3136000
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
9000
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48731000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77523000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
31268000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4098000
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3953000
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
37361000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
14831000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25541000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
419000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
17806000
CY2012Q4 us-gaap Assets
Assets
77523000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2326000
us-gaap Depreciation
Depreciation
200000
us-gaap Operating Expenses
OperatingExpenses
28657000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
324000
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001337013
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8511000
CY2012Q4 us-gaap Inventory Net
InventoryNet
1339000
CY2012Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
100000
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2362000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
684000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1971000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
867000
CY2012Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
270000
CY2012Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
11820000
CY2012Q4 infu Medical Equipment Net
MedicalEquipmentNet
15697000
CY2012Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
20852000
CY2012Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2626000
CY2012Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
13071000
CY2012Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
34193000
dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22043998 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
192200 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4765000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21851798 shares
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
805000
us-gaap Gross Profit
GrossProfit
32093000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1129000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
100000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3547000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
329000
us-gaap Operating Income Loss
OperatingIncomeLoss
3436000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2307000
us-gaap Net Income Loss
NetIncomeLoss
805000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
27912000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
41556000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
78000
us-gaap Sales Revenue Net
SalesRevenueNet
45103000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3396000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
22395000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14622000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5595000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8174000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2808000
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
100000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4782000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1418000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7281000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
us-gaap Interest Expense
InterestExpense
2636000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-588000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1972000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
15740000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4583000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
3800000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
4836000
infu Period At Which Cumulative Loss Incurred
PeriodAtWhichCumulativeLossIncurred
P3Y
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21311116 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5834000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21311116 shares
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1820000
us-gaap Gross Profit
GrossProfit
30907000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2484000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
100000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3692000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-134000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-552000
us-gaap Operating Income Loss
OperatingIncomeLoss
437000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2921000
us-gaap Net Income Loss
NetIncomeLoss
-1710000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
6747000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
38903000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
131000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
1000
us-gaap Sales Revenue Net
SalesRevenueNet
42595000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4312000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
2500000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17688000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4378000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6760000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3521000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
111000
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
100000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3119000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
665000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7635000
us-gaap Interest Expense
InterestExpense
2235000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-791000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2028000
us-gaap Depreciation
Depreciation
400000
us-gaap Operating Expenses
OperatingExpenses
30470000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-774000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
4928000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
4000000
infu Reclassifications Effect On Operating And Investing Activity
ReclassificationsEffectOnOperatingAndInvestingActivity
2400000
CY2012Q4 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-11-30
CY2012Q4 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR plus 7.25% (with a LIBOR floor of 2.0%) or the Wells Fargo prime rate plus 6.25% (with a prime rate floor of 3.0%)
CY2013Q4 infu Reduction Of Contract Price
ReductionOfContractPrice
250000
CY2012Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
500000 shares
CY2012Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000000
CY2012Q2 infu Forfeited Share Units
ForfeitedShareUnits
2000000 shares
CY2012Q2 infu Reversal Of Compensation Expense
ReversalOfCompensationExpense
1300000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2349000
CY2012Q3 us-gaap Interest Expense
InterestExpense
971000
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22075532 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
184491 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21891041 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21827365 shares
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
225836 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21601529 shares
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33000
CY2012Q3 us-gaap Gross Profit
GrossProfit
10197000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-186000
CY2012Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
100000
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1150000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-136000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
921000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1107000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
33000
CY2012Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
13025000
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
14175000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5278000
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2377000
CY2012Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
100000
CY2012Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
979000
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
670000
CY2012Q3 us-gaap Depreciation
Depreciation
100000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
9276000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-219000
CY2012Q3 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1601000
CY2012Q3 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1300000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
649000
CY2013Q3 us-gaap Gross Profit
GrossProfit
11340000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1078000
CY2013Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
100000
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1247000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1923000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-845000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
649000
CY2013Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14493000
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2750000
CY2013Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
100000
CY2013Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1795000
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2391000
CY2013Q3 us-gaap Interest Expense
InterestExpense
838000
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
648000
CY2013Q3 us-gaap Depreciation
Depreciation
100000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
9417000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
429000
CY2013Q3 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1650000
CY2013Q3 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1300000

Files In Submission

Name View Source Status
0001193125-13-437022-index-headers.html Edgar Link pending
0001193125-13-437022-index.html Edgar Link pending
0001193125-13-437022.txt Edgar Link pending
0001193125-13-437022-xbrl.zip Edgar Link pending
d615135d10q.htm Edgar Link pending
d615135dex311.htm Edgar Link pending
d615135dex312.htm Edgar Link pending
d615135dex321.htm Edgar Link pending
d615135dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
infu-20130930.xml Edgar Link completed
infu-20130930.xsd Edgar Link pending
infu-20130930_cal.xml Edgar Link unprocessable
infu-20130930_def.xml Edgar Link unprocessable
infu-20130930_lab.xml Edgar Link unprocessable
infu-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending